Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Cybin Inc
(NY:
CYBN
)
10.00
-0.38 (-3.66%)
Official Closing Price
Updated: 8:00 PM EST, Dec 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cybin Inc
< Previous
1
2
...
22
23
24
25
26
27
28
29
30
...
38
39
Next >
Revive Therapeutics, Allied Among Top Psychedelic Movers Of Today
May 19, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 21.90% at $0.29
Via
Benzinga
Study Finds Mindfulness, Psychedelic Encounters Beneficial for Mental Well-Being
May 19, 2022
Via
Investor Brand Network
Cybin, Allied Among Top Psychedelic Movers Of Today
May 18, 2022
GAINERS: Cybin (AMEX:CYBN) shares closed up 13.43% at $0.55
Via
Benzinga
Intelgenx Technologies, Cybin Among Top Psychedelic Movers Of Today
May 17, 2022
GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 16.85% at $0.32
Via
Benzinga
Takeaways from Benzinga’s Psychedelics Capital Conference
May 16, 2022
Via
Investor Brand Network
Study Discovers Mechanisms Behind Relapse After Treatment of MDD
May 12, 2022
Via
Investor Brand Network
Study Finds Alcohol Cravings Get Stronger After Consumption during Withdrawal
May 17, 2022
Via
Investor Brand Network
Aurora Sky Is No More, Stablecoins Melt Down and SAFE Banking Receives Another Boost
May 17, 2022
In this week’s Trade To Black Podcast, TDR Founder Shadd Dales, lead financial writer Benjamin A. Smith and millennial entrepreneur Anthony Varrell talk macro market, crypto, the dangers of algorithmic...
Via
Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces Participation in May 18 NYSE Trading Bell Ceremony
May 17, 2022
Via
Investor Brand Network
Cybin to Participate in NYSE Trading Bell Ceremony on May 18, 2022
May 17, 2022
From
Cybin Inc.
Via
Business Wire
Psychedelic Stock Gainers And Losers From May 16, 2022
May 16, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 25.00% at $0.22
Via
Benzinga
2 Of The 5 Cannabis Categories Advanced Slightly During Second Week Of May
May 14, 2022
The cannabis sector consists of 5 distinct categories, each performing differently from the other. Here, the stock performances during the second week of May, YTD and from the 2021 peak.
Via
Talk Markets
Psychedelic Compounds-Based Stocks Index Imploding
May 14, 2022
Our index of Psychedelic Compounds-Based Drug Stocks tracks clinical-stage startups still in R&D is down 60% YTD; -78% from its 2021 high.
Via
Talk Markets
Field Trip Health, ATAI Life Sciences Among Top Psychedelic Movers Of Today
May 13, 2022
GAINERS: Field Trip Health (NASDAQ:FTRP) shares closed up 20.93% at $0.94
Via
Benzinga
Psychedelic Stock Gainers And Losers From May 12, 2022
May 12, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 4.44% at $7.06
Via
Benzinga
Psychedelic Stock Gainers And Losers From May 11, 2022
May 11, 2022
GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 1.37% at $0.27 LOSERS:
Via
Benzinga
Study Indicates People Are Cautious About Psilocybin Therapy, More Awareness Needed
May 11, 2022
Via
Investor Brand Network
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) to Present at H.C. Wainwright Global Investment Conference
May 11, 2022
Via
Investor Brand Network
Cybin to Present at the H.C. Wainwright Global Investment Conference on May 25, 2022
May 11, 2022
From
Cybin Inc.
Via
Business Wire
Intelgenx Technologies, Compass Pathways Among Top Psychedelic Movers Of Today
May 10, 2022
GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 16.68% at $0.26
Via
Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN), Kernel Share Preliminary Results from Flow Feasibility Study
May 10, 2022
Via
Investor Brand Network
Psyched: Protesters At DEA HQ Demand Access To Psychedelics, Connecticut Approves Budget Bill With MDMA & Psilocybin Programs
May 10, 2022
Psychedelics policy action took center stage this week.
Via
Benzinga
American Billionaire Entrepreneurs Bet Millions on Psychedelics
May 10, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – May 10, 2022 – Billionaire Bob Parsons, the founder of GoDaddy, believes psychedelics can heal trauma. The Marine infantryman...
Via
FinancialNewsMedia
Exposures
Product Safety
Psychedelic Stock Gainers And Losers From May 9, 2022
May 09, 2022
GAINERS: LOSERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed down 13.47% at $3.34
Via
Benzinga
U.S. Army Sued Over Discharging Soldiers with Substance-Abuse Issues
May 09, 2022
Via
Investor Brand Network
Topics
Lawsuit
Exposures
Financial
Legal
Pilot Study By Cybin Shows That Ketamine Modifies Connectivity Between Brain Regions
May 09, 2022
Cybin Inc. (NYSE:CYBN) and Kernel, two companies that undertook a joint feasibility study to evaluate the effects ketamine has on blood flow in the brain in late March,&nbs
Via
Benzinga
Psychedelic Stocks Continue To Decline In May
May 08, 2022
The 10 companies in our Psychedelic Compounds-Based Drug Stocks Index are clinical-stage startups still in the product research and development of novel compounds with no products and no revenue.
Via
Talk Markets
TripAdvisor, Field Trip Health Among Top Psychedelic Movers Of Today
May 06, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 9.40% at $0.16
Via
Benzinga
Cybin Inc.’s (NEO: CYBN) (NYSE American: CYBN) Proprietary CYB003 Set to Move Forward in First-in-Human Phase 1/2a Clinical Trial
May 06, 2022
Via
Investor Brand Network
GH Research, Intelgenx Technologies Among Top Psychedelic Movers Of Today
May 05, 2022
GAINERS: TripAdvisor (NASDAQ:TRIP) shares closed up 5.09% at $25.80 LOSERS:
Via
Benzinga
< Previous
1
2
...
22
23
24
25
26
27
28
29
30
...
38
39
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.